Treatment, n (%) | 1LOT | 2LOT | 3LOT |
---|---|---|---|
Received treatment | 652 | 184 | 18 |
Sunitinib | 396 (60.7%) | 1 (0.5%) | – |
Originally prescribed | 375 (57.5%) | 1 (0.5%) | – |
Pazopanib intolerant | 21 (3.2%) | – | – |
Pazopanib | 246 (37.7%) | – | – |
Originally prescribed | 209 (32.1%) | – | – |
Sunitinib intolerant | 37 (5.7%) | – | – |
Axitinib | – | 105 (57.1%) | 4 (22.2%) |
Everolimus | 4 (0.6%) | 77 (41.9%) | 13 (72.2%) |
Other | 6 (0.9%) | 1 (0.5%) | 1 (5.6%) |
On treatment at FU | 140 (21.5%) | 48 (26.1%) | 6 (33.3%) |